Safety and Efficacy of Recommended Antimalarial in the Democratic Republic of the Congo

PHASE4CompletedINTERVENTIONAL
Enrollment

1,117

Participants

Timeline

Start Date

October 26, 2020

Primary Completion Date

February 8, 2022

Study Completion Date

February 8, 2022

Conditions
Malaria
Interventions
DRUG

Artesunate-amodiaquine

Artemisinin-based combination treatment

DRUG

Artemether-lumefantrine

Artemisinin-based combination treatment

Trial Locations (6)

Unknown

Centre Evangélique de Coopération, Kimpese

Centre de Santé Lupidi 1, Kapolowe

Centre de Santé de Référence Mikalayi, Kazumba

Centre de Santé de Référence Rutshuru, Rutshuru

Centre de Santé Foyer Social, Kisangani

Centre de Santé Boende 2 Nsele, Boende

All Listed Sponsors
collaborator

University of Kinshasa

OTHER

collaborator

World Health Organization

OTHER

collaborator

Institut National de Recherche Biomédicale. Kinshasa, République Démocratique du Congo

OTHER

lead

Ministry of Public Health, Democratic Republic of the Congo

OTHER_GOV

NCT04618523 - Safety and Efficacy of Recommended Antimalarial in the Democratic Republic of the Congo | Biotech Hunter | Biotech Hunter